Oxidative stress-based therapeutics in COPD.

Area of Science:

• Pulmonary Medicine
• Oxidative Stress Research
• Chronic Disease Pathogenesis

Background:

• Oxidative stress is a key factor in chronic obstructive pulmonary disease (COPD) development.
• Increased exposure to environmental oxidants and endogenous reactive oxygen species (ROS) contributes to lung oxidative stress.
• Mitochondrial dysfunction and reduced antioxidant defenses, including Nrf2 and FOXO inactivation, are implicated in COPD pathogenesis.

Purpose of the Study:

• To review the role of oxidative stress in COPD pathogenesis.
• To discuss the impact of oxidative stress on lung function and systemic health in COPD.
• To explore potential therapeutic strategies targeting oxidative stress in COPD.

Main Methods:

• Review of existing literature on oxidative stress in COPD.
• Analysis of the mechanisms linking oxidative stress to COPD pathology.
• Evaluation of current and emerging antioxidant therapies for COPD.

Main Results:

• Oxidative stress exacerbates COPD by promoting inflammation, fibrosis, emphysema, and corticosteroid resistance.
• Reduced antioxidant capacity and impaired antioxidant signaling pathways are characteristic of COPD.
• Existing antioxidant therapies (e.g., N-acetylcysteine) show modest benefits, with unclear mechanisms (antioxidant vs. mucolytic).

Conclusions:

• Oxidative stress is a critical therapeutic target for COPD.
• Developing more effective antioxidants, such as Nrf2 activators and mitochondria-targeted agents, is crucial.
• Further research is needed to validate novel antioxidant strategies for COPD treatment.